RPP-29723-54695
1 vaccination
3 coded responses
4 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 744 / OK
- Registered
- 2021-08-26
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-03
Dose 1 — Pfizer-BioNTech
-
2021-08-26
Registered in v-safe
-
2021-08-26
Survey response — day 21, dose 1MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased multiple sclerosis symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-03
Survey response — 3 months, dose 1MedDRA: Premature labour — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: pre-term laborMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · no matching call case
-
2022-02-01
Survey response — 6 months, dose 1MedDRA: Premature labour — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: preterm labor at 34 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-02-10
Call successfulParticipant prefers to complete VAERS report online
- 2022-08-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
1 check-in flagged for a call with no call center case on record
Free text
Release 9 — day 21, dose 1
Symptoms: Increased multiple sclerosis symptoms
Release 10 — 3 months, dose 1
Symptoms: pre-term labor
Release 11 — 6 months, dose 1
Symptoms: preterm labor at 34 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Multiple sclerosis | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Premature labour | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release